EVAPRO CAPSULES
Natural health product licensed in Canada
- Other names
- VITA EVAPRO CAPSULES
- Licence holder
- Vita Naturals Inc.
- NPN or DIN-HM
- 80082725
- Status
- Active licence
- Licence date
- 29 January 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Oenothera biennis Source : Graine(s) Potency : 4.6 % gamma-Linolenic acid | 50 mg | Not calculated |
| Vitamine E Source : Acétate de dl-alpha tocophéryle | 50 UI | Not calculated |
| Vitamine E Source : Acétate de dl-alpha tocophéryle | 22.5 mg AT | Not calculated |
| Extrait d'isoflavone de soja Source : Glycine max - Graine Potency : 117.19 Milligrammes d'équivalents aglycones d'isoflavones Isoflavones | 117.19 Milligrammes d'équivalents aglycones d'isoflavones | Not calculated |
Non-medicinal ingredients
Silice pyrogénée, Stéarate de magnésium, Gélatine, Cellulose microcristalline, Carbonate de calcium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes en postménopause | Not specified | 1 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to attenuate/reduce bone mineral density (BMD) loss in post-menopausal women when used in conjunction with adequate amounts of calcium and vitamin D. A factor in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80082725
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.